Sponsor Pipeline

Tanabe Pharma Corporation Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
1
Phase 3
2
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05198557 A Study of MT-0551 in Patients With Systemic Sclerosis Systemic Sclerosis Active, Not Recruiting
Phase 1/2
NCT05658562 A Study of MT-2111 in Patients With Relapsed/Refractory DLBCL Diffuse Large B-Cell Lymphoma Active, Not Recruiting
Disease Areas
Scleroderma (1) DLBCL (1)
Get alerts when Tanabe Pharma Corporation's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free